
Steven D Pearson MD
Lecturer on Population Medicine, Ambulatory Care and Prevention
Join to View Full Profile
- 133 Brookline Ave6th FloorBoston, MA 02215 
- Phone+1 617-509-9867 
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
 You already have 1 invite waiting!
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Pearson, MD is an internist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is a Lecturer on Population Medicine at Ambulatory Care and Prevention.
Education & Training
 Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990 Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990
 University of California San Francisco School of MedicineClass of 1987 University of California San Francisco School of MedicineClass of 1987
 University of California, Davis, School of MedicineClass of 1987 University of California, Davis, School of MedicineClass of 1987
Certifications & Licensure
 MA State Medical License 1989 - 2026 MA State Medical License 1989 - 2026
Publications & Presentations
PubMed
- 25 citationsCost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.Melanie D Whittington, Jonathan D Campbell, David Rind, Noemi Fluetsch, Grace A Lin
 Neurology. 2022-03-01
- 19 citationsThe effectiveness and value of aducanumab for Alzheimer's disease.Patricia G Synnott, Melanie D Whittington, Grace A. Lin, David Rind, Steven D. Pearson
 Journal of Managed Care & Specialty Pharmacy. 2021-10-29
- 24 citationsEvaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.Kouta Ito, Rick Chapman, Steven D. Pearson, Ali Tafazzoli, Kristine Yaffe
 JAMA Network Open. 2021-10-01
Press Mentions
 A Drug Costs $272,000 a Year. Not so Fast, Says New York StateJune 24th, 2018 A Drug Costs $272,000 a Year. Not so Fast, Says New York StateJune 24th, 2018
 Affording Miracles: As Biotech Victories in Gene Therapy Excite, Costs Spur Quest for New Ways to PayJune 7th, 2018 Affording Miracles: As Biotech Victories in Gene Therapy Excite, Costs Spur Quest for New Ways to PayJune 7th, 2018









